This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
The company also expects revenue from all of 2024 to be $45 billion, lower than the range of $45.4 Lilly said the GLP-1 drugs Mounjaro and Zepbound are expected to have brought in $3.5 billion and $1.9 billion, respectively, in the fourth quarter. billion to $46 billion that it had previously guided.
In May 2024 , nearly 90% of pharmacies were closed for a day as thousands of pharmacists protested over “over drug shortages, pharmacy closures and fears medications could be sold online, as well as higher pay.”
Their study demonstrating the power of sewage as an early-warning system for outbreaks won the 2024 STAT Madness popular vote. Building off that early polio work from the 1940s, researchers from the Baylor College of Medicine analyzed public wastewater and showed they could detect over 450 disease-causing viruses. Read the rest…
LONDON — A pair of scientists who discovered a type of RNA molecule that helps control the activity of genes — allowing our cells to perform all their myriad of functions in different tissues throughout the body — won the 2024 Nobel Prize in medicine or physiology on Monday.
Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations.
The STAT Diversity and Inclusion Committee presents STAT’s 2024 Diversity and Inclusion Report. Here, we share the self-reported gender and racial/ethnic demographics of our staff from STAT’s inception in 2015 through 2023, as well as our 2023 new hire demographics.
But after two years of steady decline, 2024 might finally prove them right. Here are three major themes that we expect to drive the news in 2024 and determine whether biotech’s comeback is a sustainable trend or an interest-rate phenomenon.
Morgan Healthcare Conference, we discuss how a spate of deals and some intermittent sunshine seem to have brightened the outlook for biotech at the outset of 2024. Recording from the J.P. We also talk about the latest twist in the Sarepta Therapeutics saga, a ubiquitous dealmaker, and life on the party circuit. Read the rest…
8-11, 2024 — setting the stage for the rest of the year in health, science, and medicine. The annual J.P. Morgan Healthcare Conference, the largest event of its kind, will take place in San Francisco, Jan. The event is a gathering space for investors, entrepreneurs, and others. 8 looking at what’s next in biotech.
It had been five months since I’d applied to the program, after being discharged from the hospital in August 2024 as a new full-time wheelchair user. The letter informed me that I had been approved for Medicaid-funded Home and Community-Based Services (HCBS), a form of long-term care.
ASBM Exhibits at ACR Convergence 2024 During November, ASBM was proud to again participate in the American College of Rheumatology (ACR) Convergence 2024, held from November 14-19 in Washington, DC. Read more about ACR Convergence 2024 here. The approval of Steqeyma brings the total number of biosimilars approved in 2024 to 17.
Here are three CRISPR developments we’re watching in 2024: Continue to STAT+ to read the full story… The landmark decision paves the way for in vivo therapies, which edit cells inside the body, to reach patients, as well as treatments based on more efficient genome editors with fancier DNA-altering tricks up their sleeves.
SAN FRANCISCO — Eric Tokat, biotech’s most prolific dealmaker, believes 2024 will be another strong year for acquisitions, driven by Big Pharma’s need to restock pipelines with medicines that can generate sales in the coming years. That’s not idle speculation.
million in December 2024 from $4.53 million in November 2024. per cent decline in funding in December 2024, when compared with the $75 million in December 2023. 3Gen Consulting, Laurus Bio, and Orange Health reported the biggest funding rounds in December 2024, raising $22 million, $18.9 per cent to $69.8 per cent and 7.3
Pfizer said Wednesday that its 2024 profits would fall far below investor expectations, leading shares to tumble 7% in early trading. Pfizer said that its full-year revenue for 2024 should fall between $58.5 The reduced earnings numbers cap a difficult year for the drug giant. billion and $61.5
ACG Engineering, a division of ACG specialising in manufacturing solutions for the global pharmaceutical and nutraceutical industries, introduced its new ADAPT X feeder at CPhI & PMEC India 2024 in Delhi. Launching ADAPT X at PMEC 2024 allows us to demonstrate the transformative impact of this feeder to industry leaders,” he added.
CPHI & PMEC India 2024 concluded successfully at the India Expo Centre in Greater Noida, Delhi-NCR, from November 26th to 28th. The post India’s pharma industry showcased at CPHI & PMEC India 2024 appeared first on Express Pharma.
The 64 contestants whose discoveries and innovations have been selected for the 2024 edition of STAT Madness come from 50 institutions across the U.S. The teams include a Nobel laureate (Jennifer Doudna) and biotech big shots (Robert Langer and David Liu), but also up-and-comers.
As Election Day 2024 gets closer, STAT’s First Opinion asked executives from leading biotech and pharmaceutical companies to reflect on how their industry is being portrayed in the presidential campaign — and what their hopes are for a new presidential administration. Read Read an excerpt from each below.
This year’s PharmaVoice 100 encompasses the industry’s ongoing revolutions and leaders who are not only navigating these changes, but at times, forging new paths for others to follow.
Community Pharmacy Contractual Framework negotiations have now begun for the 2024/25 and 2025/26 funding agreements, the government has announced. Minister of state for care Stephen Kinnock […] The post BREAKING: Pharmacy contract negotiations begin for 2024/25 and 2025/26 appeared first on The Pharmacist.
The company indicated that the investigation began in 2017 and picked up in intensity in late 2024 and early 2025. The SEC filing states that on Feb. Continue to STAT+ to read the full story…
And what’s going to move markets in 2024? We also look ahead to the biggest biotech stories coming in 2024, including some major data readouts and a few pivotal FDA decisions. Why are rich biotechs cutting costs? Has JPM Week already worn off? Read the rest…
“I’ve won 10 to 20 awards in the last 20 years, but never had a press conference with cameras and nothing like this,” Ruvkun, who along with Victor Ambros received the 2024 award in medicine or physiology on Monday, said at a press conference at Massachusetts General Hospital.
In 2024, about 8% of pediatrics positions went unfilled , an increase from about 3% in 2023. On Friday, medical students around the U.S. will learn what residency program they have matched into. Match Day is not just momentous for those students, though.
STAT took a look at 20 large nonprofit health systems and found that all but four reported higher operating and net margins in the first three months of 2024 compared with the same period in 2023. Hospitals are seeing more patients and cutting down on the expensive contract labor they relied on during the Covid-19 pandemic.
As Election Day 2024 gets closer, STAT’s First Opinion asked executives from leading biotech and pharmaceutical companies to reflect on how their industry is being portrayed in the presidential campaign — and what their hopes are for a new presidential administration. With all eyes currently on the upcoming U.S.
According to data published this week by advisory Rock Health, startups using AI made up 37% of 2024’s digital health funding. Since OpenAI’s ChatGPT launched a wave of enthusiasm about the potential of AI, the technology has become a specific target for health care investors.
The pharma giant on Thursday boosted its forecast for 2024 sales to a range of $45.4 Eli Lilly raised its full-year revenue guidance by $3 billion, driven by massive sales of its GLP-1-based diabetes and obesity drugs Mounjaro and Zepbound. billion to $46.6 billion from the previously guided range of $42.4 from the previously guided $13.50
Though health savings accounts, pharmacies, and major hospitals have all been attacked in 2024, a single data breach accounted for the vast majority of people’s data being exposed: Change Healthcare. Year after year, more Americans are affected by health care data breaches.
The Pharmaceuticals and Medical Devices Bureau of India (PMBI), the implementing agency of the Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP) is participating in the 43rd India International Trade Fair (IITF) 2024.
Greetings from JPM Week 2024! Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.
STAT’s taking a look at some of the recent health policy trends that states will start to implement in 2024. For most states, the new year means a new legislative session.
In November 2024, the pharma and healthcare industry reported 95 deals worth $14.8 billion, compared to the last 12-month (November 2023 to October 2024) average of 102 deals worth $16.8 These three major deals contributed 25 per cent of the total deal value during November 2024.
Welcome to STAT Madness, a bracket-style contest to find the best innovation in science and medicine. Click on each matchup for a short summary of each school’s pioneering research. Then pick your favorites. Help us crown a champ! Previous Winners | Official Rules | FAQ
Freudenberg, a worldwide technology business based in Germany, will attend CPhI & PMEC India 2024 on November 26-28, 2024. The post Freudenberg launches new products at CPhI & PMEC 2024 for Indian customers appeared first on Express Pharma. The booth, located in Hall No. 15 – No.
Morgan Healthcare Conference is upon us, bringing its frenetic meetings, crowded hallways, and hotel rooms so expensive that even the pharmaceutical industry complains about what a free market does to the prices of scarce goods.
That suggests to me that 2024 will be a better year for the industry’s job seekers. My time was packed with the usual mix of requests from potential, current, and former clients as well as investors to discuss search projects, and of course the meeting requests from potential candidates. ” requests as last year.
The post 9th Advanced GMP Workshop 2024 was organised by IPA appeared first on Express Pharma. IPA also announced the dates of the flagship pharma event of the year – the 10 th Global Pharmaceutical Quality Summit, which will be organised on February 27-28, 2025 in Mumbai.
The 17th edition of CPHI & PMEC India, organised by Informa Markets in India, returns in an advanced format, scheduled from November 26-28, 2024, at the India Expo Centre, Greater Noida, Delhi-NCR. India’s pharma industry is on an impressive growth trajectory, expected to reach $65 billion by 2024 and to double to $130 billion by 2030.
Department of Health and Human Services, Warren accused the company of “outrageous profiteering” because the maneuver cost Medicaid nearly $1 billion in 2024. In a letter sent Tuesday to the Office of Inspector General at the U.S.
We organize all of the trending information in your field so you don't have to. Join 11,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content